INHIBITION OF CHOLESTEROL AND SPHINGOLIPID SYNTHESIS CAUSES PARADOXICAL EFFECTS ON PERMEABILITY BARRIER HOMEOSTASIS

被引:30
|
作者
MAN, MQ
FEINGOLD, KR
ELIAS, PM
机构
[1] VET ADM MED CTR,DERMATOL SERV 190,4150 CLEMENT ST,SAN FRANCISCO,CA 94121
[2] VET ADM MED CTR,METAB SECT,SAN FRANCISCO,CA 94121
[3] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT DERMATOL,SAN FRANCISCO,CA 94143
[4] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT CHEM,SAN FRANCISCO,CA 94143
关键词
D O I
10.1111/1523-1747.ep12363729
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cholesterol, fatty acid, and sphingolipid synthesis are required for barrier homeostasis, as demonstrated by studies where synthesis of these species is stimulated in parallel with barrier repair. Moreover, blockade of synthesis of these lipids with inhibitors of two of the rate-limiting enzymes, HMGCoA reductase (lovastatin, fluvastatin) and serine palmitoyl transferase (beta-chloroalanine), alters the kinetics of barrier repair. Whereas these studies demonstrated a requirement for these lipids individually, we asked here whether these lipids are required in either an additive or cooperative fashion. We applied each class of inhibitor alone or the two classes of inhibitors together to acetone-treated skin, or each class separately to essential fatty acid deficient murine skin. When fluvastatin or beta-chloroalanine was applied individually to acetone-treated skin, each caused a delay in the early or late stages of barrier recovery, respectively (assessed as transepidermal water loss). However, when applied together they caused no further worsening at the early time point and a paradoxical improvement at the later time points. This improvement correlated with an accelerated return of sphingolipids, which was perhaps due to a global stimulation of lipid synthesis induced by HMGCoA reductase inhibitors. In essential fatty acid deficient animals, inhibition of HMGCoA reductase caused drastic worsening of both clinical appearance and barrier function, but beta-chloroalanine caused a paradoxical improvement, which correlated with a significant reduction in epidermal sphingolipids. These results are consistent with a requirement for both cholesterol and sphingolipids for barrier homeostasis, and also with the suggestion that both of these lipids must be present (with free fatty acids) for optimal barrier function.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 45 条
  • [41] Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: Liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing
    Man, Mao-Qiang
    Choi, Eung-Ho
    Schmuth, Matt
    Crumrine, Debra
    Uchida, Yoshikazu
    Elias, Peter M.
    Holleran, Walter M.
    Feingold, Kenneth R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (02) : 386 - 392
  • [42] The Protective Effects of Juglanin in Cerebral Ischemia Reduce Blood-Brain Barrier Permeability via Inhibition of VEGF/VEGFR2 Signaling
    Liu, Jia
    Chen, Lei
    Zhang, Xin
    Pan, Lixiao
    Jiang, Lili
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3165 - 3175
  • [43] Pharmacological effects of Artocarpus lakoocha methanol extract on inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway
    Shafaq
    Akhtar, Tasleem
    Ishaq, Hafiz Muhammad
    Shahzad, Muhammad
    PHARMACEUTICAL BIOLOGY, 2022, 60 (01) : 840 - 845
  • [44] Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells
    Fanaee-Danesh, Elham
    Gali, Chaitanya Chakravarthi
    Tadic, Jelena
    Zandl-Lang, Martina
    Kober, Alexandra Carmen
    Roca Agujetas, Vicente
    de Dios, Cristina
    Tam-Amersdorfer, Carmen
    Stracke, Anika
    Albrecher, Nicole Maria
    Manavalan, Anil Paul Chirackal
    Reiter, Marielies
    Sun, Yidan
    Colell, Anna
    Madeo, Frank
    Malle, Ernst
    Panzenboeck, Ute
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (09): : 2224 - 2245
  • [45] EFFECTS OF N-(4-METHYLBENZYLTHIOCARBONYL)-L-PHENYLALANINE (KF-1492), A NEW PHENYLALANINE DERIVATIVE, ON LIPID-SYNTHESIS INVIVO INHIBITION OF HEPATIC CHOLESTEROL-SYNTHESIS AND 3-HYDROXY-3-METHYLGLUTARYL-CO-A REDUCTASE
    ISHII, A
    DEGUCHI, T
    MARUMO, H
    TANAKA, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1981, 4 (12): : 933 - 939